“…This includes tissue factor (TF), thrombin receptor (PAR-1) along with other protease activated receptors (PARs), urokinase receptor (uPAR), thrombomodulin (TM), endothelial protein C receptor (EPCR), receptors for protein S (TAM group), integrins, and growth factor receptors that can be transactivated by the coagulation system [10][11][12][13][14]. These molecular interactions activate intracellular signalling pathways and change the expression of several genes [15,16], including mediators of angiogenesis, inflammation and other processes relevant to cancer [10,[17][18][19]. In this manner, the various components of the haemostatic circuitry, such as factor VIIa, Xa, thrombin, fibrin, proteins C and S and others, in conjunction…”